Recombinant interleukin-7 treatment of refractory <i>Mycobacterium avium</i> complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trial

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Infectious Disease
Published
2025-05-10
DOI
https://doi.org/10.1177/20499361251339300
Citations
1
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recombinant interleukin-7 treatment of refractory Mycobacterium avium complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trial

Michel Morre, Andrew H. Walton, Alina Ulezko Antonova, Sanjeev Bhalla et al.
1 citations
Therapeutic Advances in Infectious Disease
Mycobacterium research and diagnosis
1.35
article

Recombinant interleukin-7 treatment of refractory Mycobacterium avium complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trial

Michel Morre, Andrew H. Walton, Alina Ulezko Antonova, Sanjeev Bhalla, Andrej Spec, Carlos Mejía-Chew, Marco Colonna, Alexandra Dram, Richard Hotchkiss
article en
1 citations

Abstract

No abstract available for this paper.
Therapeutic Advances in Infectious DiseaseVol. 12
Washington University in St. Louis (US)
Good health and well-being
Openalex Percentile: Top 20%
Mycobacterium research and diagnosis
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.